Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23


[Plastic arts workshop, in search of the therapeutic].

Guyader C.

Soins Psychiatr. 2019 Jul - Aug;40(323):35-38. doi: 10.1016/j.spsy.2019.05.011. French.


Haploid genetic screens identify genetic vulnerabilities to microtubule-targeting agents.

Gerhards NM, Blomen VA, Mutlu M, Nieuwenhuis J, Howald D, Guyader C, Jonkers J, Brummelkamp TR, Rottenberg S.

Mol Oncol. 2018 Jun;12(6):953-971. doi: 10.1002/1878-0261.12307. Epub 2018 May 1.


Selected Alkylating Agents Can Overcome Drug Tolerance of G0-like Tumor Cells and Eradicate BRCA1-Deficient Mammary Tumors in Mice.

Pajic M, Blatter S, Guyader C, Gonggrijp M, Kersbergen A, Küçükosmanoğlu A, Sol W, Drost R, Jonkers J, Borst P, Rottenberg S.

Clin Cancer Res. 2017 Nov 15;23(22):7020-7033. doi: 10.1158/1078-0432.CCR-17-1279. Epub 2017 Aug 18.


Autonomously folded α-helical lockers promote RNAi.

Guyader CP, Lamarre B, De Santis E, Noble JE, Slater NK, Ryadnov MG.

Sci Rep. 2016 Oct 10;6:35012. doi: 10.1038/srep35012.


Subunit composition of VRAC channels determines substrate specificity and cellular resistance to Pt-based anti-cancer drugs.

Planells-Cases R, Lutter D, Guyader C, Gerhards NM, Ullrich F, Elger DA, Kucukosmanoglu A, Xu G, Voss FK, Reincke SM, Stauber T, Blomen VA, Vis DJ, Wessels LF, Brummelkamp TR, Borst P, Rottenberg S, Jentsch TJ.

EMBO J. 2015 Dec 14;34(24):2993-3008. doi: 10.15252/embj.201592409. Epub 2015 Nov 3.


BRCA2-deficient sarcomatoid mammary tumors exhibit multidrug resistance.

Jaspers JE, Sol W, Kersbergen A, Schlicker A, Guyader C, Xu G, Wessels L, Borst P, Jonkers J, Rottenberg S.

Cancer Res. 2015 Feb 15;75(4):732-41. doi: 10.1158/0008-5472.CAN-14-0839. Epub 2014 Dec 15.


Risk of hormone escape in a human prostate cancer model depends on therapy modalities and can be reduced by tyrosine kinase inhibitors.

Guyader C, Céraline J, Gravier E, Morin A, Michel S, Erdmann E, de Pinieux G, Cabon F, Bergerat JP, Poupon MF, Oudard S.

PLoS One. 2012;7(8):e42252. doi: 10.1371/journal.pone.0042252. Epub 2012 Aug 6.


Gene Expression Data to Mouse Atlas Registration Using a Nonlinear Elasticity Smoother and Landmark Points Constraints.

Lin T, Guyader CL, Dinov I, Thompson P, Toga A, Vese L.

J Sci Comput. 2012 Mar;50(3). doi: 10.1007/s10915-011-9563-6.


Molecular profiling of patient-derived breast cancer xenografts.

Reyal F, Guyader C, Decraene C, Lucchesi C, Auger N, Assayag F, De Plater L, Gentien D, Poupon MF, Cottu P, De Cremoux P, Gestraud P, Vincent-Salomon A, Fontaine JJ, Roman-Roman S, Delattre O, Decaudin D, Marangoni E.

Breast Cancer Res. 2012 Jan 16;14(1):R11.


On the construction of topology-preserving deformation fields.

Le Guyader C, Apprato D, Gout C.

IEEE Trans Image Process. 2012 Apr;21(4):1587-99. doi: 10.1109/TIP.2011.2177850. Epub 2011 Dec 1.


Sugars comparable to glutathione as hemoglobin oxidation protectants during vacuum drying.

Lynch AL, Dury BA, Guyader CP, Slater NK.

Biopreserv Biobank. 2011 Dec;9(4):411-3. doi: 10.1089/bio.2011.0021. Epub 2011 Nov 11.


Modeling of response to endocrine therapy in a panel of human luminal breast cancer xenografts.

Cottu P, Marangoni E, Assayag F, de Cremoux P, Vincent-Salomon A, Guyader Ch, de Plater L, Elbaz C, Karboul N, Fontaine JJ, Chateau-Joubert S, Boudou-Rouquette P, Alran S, Dangles-Marie V, Gentien D, Poupon MF, Decaudin D.

Breast Cancer Res Treat. 2012 Jun;133(2):595-606. doi: 10.1007/s10549-011-1815-5. Epub 2011 Oct 16.


Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation.

de Plater L, Laugé A, Guyader C, Poupon MF, Assayag F, de Cremoux P, Vincent-Salomon A, Stoppa-Lyonnet D, Sigal-Zafrani B, Fontaine JJ, Brough R, Lord CJ, Ashworth A, Cottu P, Decaudin D, Marangoni E.

Br J Cancer. 2010 Oct 12;103(8):1192-200. doi: 10.1038/sj.bjc.6605900. Epub 2010 Sep 28.


A preclinical therapeutic schedule optimizing docetaxel plus estramustine administration in prostate cancer.

Dahmani A, de Plater L, Guyader C, Fontaine JJ, Berniard A, Assayag F, Beuzeboc P, Marangoni E, Némati F, Poupon MF, Pasik C, Oudard S, Decaudin D.

Anticancer Drugs. 2010 Nov;21(10):927-31. doi: 10.1097/CAD.0b013e32833db887.


Hormone escape is associated with genomic instability in a human prostate cancer model.

Legrier ME, Guyader C, Céraline J, Dutrillaux B, Oudard S, Poupon MF, Auger N.

Int J Cancer. 2009 Mar 1;124(5):1103-11. doi: 10.1002/ijc.24073.


Self-repelling snakes for topology-preserving segmentation models.

Le Guyader C, Vese LA.

IEEE Trans Image Process. 2008 May;17(5):767-79. doi: 10.1109/TIP.2008.919951.


[New targeted therapies in hormone-refractory prostate cancer].

Oudard S, Banu E, Scotte F, Beuzeboc P, Guyader C, Medioni J.

Bull Cancer. 2007 Jul;94(7 Suppl):F62-8. Review. French.


A new model of patient tumor-derived breast cancer xenografts for preclinical assays.

Marangoni E, Vincent-Salomon A, Auger N, Degeorges A, Assayag F, de Cremoux P, de Plater L, Guyader C, De Pinieux G, Judde JG, Rebucci M, Tran-Perennou C, Sastre-Garau X, Sigal-Zafrani B, Delattre O, Diéras V, Poupon MF.

Clin Cancer Res. 2007 Jul 1;13(13):3989-98.


Potentiation of antitumour activity of docetaxel by combination with trastuzumab in a human prostate cancer xenograft model and underlying mechanisms.

Legrier ME, Oudard S, Judde JG, Guyader C, de Pinieux G, Boyé K, de Cremoux P, Dutrillaux B, Poupon MF.

Br J Cancer. 2007 Jan 29;96(2):269-76. Epub 2007 Jan 9.


Capacitation of fresh bovine spermatozoa on bovine epithelial oviduct cell monolayers.

Guyader C, Chupin D.

Theriogenology. 1991 Sep;36(3):505-12.


In vitro fertilization of sheep oocytes matured in vivo.

Cognie Y, Guerin Y, Guyader C, Poulin N, Crozet N.

Theriogenology. 1991 Feb;35(2):393-400.


[Congenital striata lichenoid keratosis].

Barriére H, Litoux P, Bureau B, Welin J, Guyader C.

Ann Dermatol Venereol. 1977 Nov;104(11):767-9. French. No abstract available.


Striatal evoked inhibition of identified nigro-thalamic neurons.

Deniau JM, Feger J, Le Guyader C.

Brain Res. 1976 Mar 5;104(1):152-6. No abstract available.


Supplemental Content

Loading ...
Support Center